1/22/2003

In an effort to more strongly compete with rival Gillette, Energizer yesterday agreed to pay $930 million for Pfizer's Schick-Wilkinson Sword subsidiary. The move also benefits Pfizer, which is selling its non-core assets to focus more on its pharmaceuticals.

Related Summaries